글로벌 인공 혈액 대체 시장 – 2030년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Healthcare Global Artificial Blood Substitutes Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

글로벌 인공 혈액 대체 시장 – 2030년까지의 산업 동향 및 예측

  • Healthcare
  • Upcoming Report
  • Dec 2023
  • Global
  • 350 Pages
  • 테이블 수: 220
  • 그림 수: 60
지금 구매 지금 구매

Global Artificial Blood Substitutes Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Diagram 예측 기간
 2023 –2030
Diagram 시장 규모(기준 연도)
 USD 6.67 Million
Diagram 시장 규모(예측 연도)
 USD 29.24 Million
Diagram 연평균 성장률
 %
Diagram 주요 시장 플레이어
  • Aurum Biosciences
  • HEMARINA
  • Hemoglobin Oxygen Therapeutics LLC
  • KaloCyte
  • SpheriTech

글로벌 인공 혈액 대체 시장, 제품 유형(퍼플루오로카본(PFC), 헤모글로빈 기반 산소 운반체(HBOC)), 출처(인간 혈액, 동물 혈액, 미생물 기반 재조합 HB, 합성 폴리머, 줄기 세포), 응용 분야(심혈관 질환, 악성 신생물, 부상, 신생아 상태, 장기 이식, 모체 상태), 최종 사용자(병원 및 진료소, 혈액 은행, 기타) - 산업 동향 및 2030년까지의 예측.

인공혈액대체제 시장

인공 혈액 대체품 시장 분석 및 규모

인공 혈액은 외상으로 인한 혈액 손실 후 산소 공급을 회복하는 데 사용되며, 특히 응급 및 전장 상황에서 수술 중 수혈의 필요성을 방지합니다. 이는 혈액의 가장 중요한 기능인 산소와 이산화탄소의 운반을 수행할 수 있는 대체 혈액 제품입니다 . 인공 혈액은 특히 대규모 재난으로 인한 심각한 혈액 손실 시 생명을 구하는 조치가 될 수 있지만, 현재 개발 중인 제품은 감염과 싸우는 것과 같은 혈액의 2차 기능을 수행할 수 없습니다.

Data Bridge Market Research는 2022년에 667만 달러였던 글로벌 인공 혈액 대체제 시장이 2030년까지 2,924만 달러에 도달할 것으로 예상되며 예측 기간 동안 20.4%의 CAGR을 기록할 가능성이 높다고 분석했습니다. "병원 및 진료소"는 더 나은 진단 및 치료 방법에 대한 수요가 증가함에 따라 글로벌 인공 혈액 대체제 시장의 최종 사용자 부문을 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화

보고서 메트릭

세부

예측 기간

2023년부터 2030년까지

기준 연도

2022

역사적 연도

2021 (2016-2020까지 사용자 정의 가능)

양적 단위

매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시됨

다루는 세그먼트

제품 유형별(퍼플루오로카본(PFC), 헤모글로빈 기반 산소 운반체(HBOC)), 출처별(인간 혈액, 동물 혈액, 미생물 기반 재조합 HB, 합성 폴리머, 줄기 세포), 응용 분야별(심혈관 질환, 악성 신생물, 부상, 신생아 상태, 장기 이식 , 모성 상태), 최종 사용자별(병원 및 진료소, 혈액 은행, 기타)

적용 국가

미국, 북미의 캐나다 및 멕시코, 독일, 프랑스, ​​영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양의 기타 지역, 사우디 아라비아, UAE, 남아프리카, 이집트, 이스라엘, 중동 및 아프리카의 기타 지역, 브라질, 아르헨티나 및 남미의 기타 지역

시장 참여자 포함

Aurum Biosciences (U.K.), HEMARINA (France), Hemoglobin Oxygen Therapeutics LLC (U.S.), KaloCyte Inc. (U.S.), SpheriTech Ltd. (U.K.), Centrum Medyczne VisusMed (Poland), European Medicines Agency (Netherlands), OPK Biotech Inc. (U.S.), NuvOx Pharma (U.S.), Prolong Pharmaceuticals, LLC (U.S.), Boston Pharmaceuticals (U.S.), OXYVITA Inc (U.S.), NanoBlood LLC (U.S.)

Market Opportunities
  • Increasing demand for artificial blood substitutes due to the rising incidence of road accidents
  • Growing awareness about the benefits of artificial blood substitutes
  • Technological advancements in blood transfusion operations

 

Market Definition

Oxygen therapeutics or haemoglobin-based oxygen carriers are other terms for artificial blood substitutes. It is used to simulate the function of biological blood and to provide an alternative to blood transfusion. Artificial blood is used to replace transfusions of banked red blood cells and is designed to overcome limitations such as a lack of blood donor, high risk of contamination, and the need for cross matching. Allogenic blood transfusions carry a number of risks, including the transmission of infectious disease, transfusion reactions, transfusion-related acute lung injury, delayed postoperative wound healing, immunomodulation, and the risk of cancer recurrence. It holds the promise of novel, life-saving medical treatments.

Global Artificial Blood Substitutes Market Dynamics

Drivers

  • Rising usage of artificial blood substitutes

Animal blood, human blood, microorganisms, recombinant Hb, stem cells, and other sources are used to create artificial blood. Artificial blood has several advantages over human blood because it belongs to a universal blood group and can be administered to patients regardless of blood type. Artificial blood substitutes also do not cause any immunological reactions. Furthermore, artificial blood substitute eliminates the risk of infectious diseases or contamination during transfusion and has a longer shelf life than human blood, as it can be stored for 3 years at room temperature or more, whereas human blood has a 42-day shelf life. Artificial blood can be used in emergency situations and is easily stored. It is also an excellent option for the patients who doesn’t accept blood from donors due to their religious beliefs. These all are the certain factors which propel the growth of the market.

  • Rising awareness of the benefits of artificial blood

Rising awareness of the benefits of artificial blood and rising demand for artificial blood, combined with an insufficient number of blood donors is bolstering the market growth. When blood substitutes are manufactured, bacteria and viruses can be destroyed. This reduces the risk of infectious diseases in blood transfusions, which is a major problem in many parts of Sub-Saharan Africa. An increase in research and development on artificial blood is boosting the global artificial blood substitutes market.

Opportunity

  • Growing number of surgical procedures

A growing number of surgical procedures necessitate the use of artificial blood substitutes in place of donated human blood plasma or red cells.  Increased funding for research on artificial blood substitutes by government and private organizations, which is likely to result in innovations and new product launches.

Restraints/Challenges

  • High cost of artificial blood substitutes

High cost of artificial blood substitutes and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. For instance, most hemoglobin-based products only last 20-30 hours in the body. In comparison, whole blood transfusions last 34 days. Furthermore, these blood substitutes do not mimic the ability of blood to fight diseases and clot.

This artificial blood substitutes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the artificial blood substitutes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent developments

  • In November 2020, Hemarina published a scientific report on the anti-inflammatory and antibacterial properties of M 101, an oxygen transporter for the treatment of periodontitis. This study validated the quality of M 101 molecule, which is derived from marine lugworm haemoglobin
  • In June 2020, KaloCyte, Inc. received a USD 300,000 grant from the University System of Maryland (USM) Momentum Fund to develop ErythroMer, a synthetic, bio-inspired red blood substitute. This funding has enabled the company to accelerate the development of the ErythroMer
  • In May 2020, KaloCyte, Inc. was awarded a USD 373,000 Small Business Innovation Research (SBIR) Phase I grant by the National Institutes of Health (NIH). This grant assisted the company in advancing the KaloCyte product to preclinical safety and efficacy testing in preparation for market launch

Global Artificial Blood Substitutes Market Scope

The artificial blood substitutes market is segmented on the basis of product type, source, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Perflurocarbon (PFCs)
  • Hemoglobin-Based Oxygen Carries (HBOCs)

 Source

  • Human Blood
  • Animal Blood
  • Microorganism Based Recombinant HB
  • Synthetic Polymers and Stem Cells

 애플리케이션

  • 심혈관 질환
  • 악성 신생물
  • 부상
  • 신생아 상태
  • 장기 이식과 모성 상태

 최종 사용자

  • 병원 및 진료소
  • 혈액은행
  • 기타

 글로벌 인공 혈액 대체 시장 지역 분석/통찰력

인공 혈액 대체제 시장을 분석하고, 위에 언급된 대로 국가, 제품 유형, 출처, 응용 분야 및 최종 사용자별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

인공 혈액 대체제 시장 보고서에서 다루는 국가는 다음과 같습니다. 북미의 미국, 캐나다 및 멕시코, 독일, 프랑스, ​​영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽 국가, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양(APAC)의 기타 아시아 태평양 국가(APAC), 사우디 아라비아, UAE, 남아프리카 공화국, 이집트, 이스라엘, 중동 및 아프리카(MEA)의 일부인 기타 중동 및 아프리카(MEA), 브라질, 아르헨티나, 남아메리카의 일부인 기타 남아메리카.

교통사고 증가, 만성질환 유병률 증가, 질병으로 인한 수술 증가 등의 요인으로 인해 북미 지역이 인공혈액 대체제 시장을 장악할 것으로 예상됩니다.

아시아 태평양 지역은 2022년에서 2029년까지의 예측 기간 동안 가장 높은 성장률을 기록할 것으로 예상되며, 이는 당뇨병 망막병증으로 인한 실명으로 인한 안구 수술 관련 수술의 증가와 당뇨병 사례의 증가와 같은 요인으로 인해 이 지역에서 사용되는 HBOC의 주요 응용 분야입니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 글로벌 인공 혈액 대체 시장 점유율 분석

인공 혈액 대체제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 인공 혈액 대체제 시장과 관련된 회사의 초점에만 관련이 있습니다.

인공 혈액 대체제 시장에서 활동하는 주요 기업은 다음과 같습니다.

  • Aurum Biosciences (영국)
  • 헤마리나(프랑스)
  • 헤모글로빈 산소 테라퓨틱스 LLC(미국)
  • 칼로사이트 주식회사 (미국)
  • SpheriTech Ltd. (영국)
  • Centrum Mediczne VisusMed (폴란드)
  • 유럽 ​​의약품 기관(네덜란드)
  • OPK 바이오텍 주식회사 (미국)
  • NuvOx Pharma(미국)
  • Prolong Pharmaceuticals, LLC(미국)
  • 보스턴 파마슈티컬스(미국)
  • 옥시비타 주식회사(미국)
  • 나노블러드 LLC(미국)

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW OF GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET
    4. LIMITATIONS
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. Currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. primary interviews with key opinion leaders
    7. MULTIVARIATE MODELLING
    8. PRODUCT TYPE LIFELINE CURVE
    9. DBMR MARKET POSITION GRID
    10. market APPLICATION coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. PREMIUM INSIGHTS
  5. PATENT ANALYSIS OF GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET
    1. DBMR ANALYSIS
    2. COUNTRY-LEVEL ANALYSIS
    3. YEARWISE ANALYSIS
  6. GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: PIPELINE ANALYSIS
  7. Market Overview
    1. drivers
      1. IncreasE IN demand for blood transfusion
      2. Increased funding for product development
      3. rise in blood-related disorders and trauma cases
      4. limited availability of fresh blood and small storage periods of fresh blood
    2. Restraints
      1. stringent regulatory approval process
      2. high-cost production of artificial blood substitute
      3. unawareness about the artificial blood substitutes
    3. OPPORTUNITIES
      1. increase in awareness regarding the advantages of artificial blood over human blood
      2. risE IN demand for blood substituteS and insufficient number of blood donors
      3. RISE IN number of research & developments on artificial blood
      4. ample amount of sources for production of artificial blood substitute
    4. Challenges
      1. instability of artificial blood product
      2. extended clinical trails
      3. side effects of artificial blood substitutes
  8. IMPACT OF COVID-19 ON THE GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET
    1. Aftermath of COVID-19
    2. Impact on Supply and Demand
    3. The increasing demand for blood transfusion is leading the artificial blood substitutes market.
    4. Conclusion
  9. Global Artificial blood substitutes market, by Product Type
    1. overview
    2. Hemoglobin-Based Oxygen Carries (HBOCS)
      1. oxyglobin
      2. hemopure
    3. Perfluorocarbon (PFCS)
      1. perftoran
      2. others
  10. Global Artificial blood substitutes market, by Source
    1. overview
    2. animal blood
    3. Human Blood
    4. Microorganism Based Recombinant Hb
    5. Stem Cells
    6. Synthetic Polymers
  11. Global Artificial blood substitutes market, by Application
    1. overview
    2. injuries
    3. Cardiovascular Diseases
    4. Organ Transplant
    5. Maternal Condition
    6. Malignant Neoplasma
    7. Neonatal Conditions
  12. Global Artificial blood substitutes market, by End user
    1. overview
    2. hospital and clinics
    3. blood banks
    4. others
  13. Global Artificial blood SUBSTITUTEs MARKET, by Region
    1. Overview
    2. NORTH AMERICA
      1. U.S.
      2. MEXICO
    3. Middle East & Africa
      1. South Africa
      2. Rest Of Middle East & Africa
    4. EUROPE
      1. FRANCE
      2. RUSSIA
      3. NETHERLAND
      4. U.K.
      5. REST OF EUROPE
    5. asia-pacific
      1. China
      2. Rest Of asia-pacific
  14. global artificial blood substitutes market: COMPANY landscape
    1. company share analysis: Global
    2. global artificial blood substitutes market: company share 2020 (%)
    3. company share analysis: North America
    4. North America artificial blood substitutes market: company share 2020 (%)
    5. company share analysis: Europe
    6. Europe artificial blood substitutes market: company share 2020 (%)
  15. swot
  16. company profile
    1. kalocyte, inc.
      1. COMPANY SNAPSHOT
      2. Company sahre Analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    2. hemarina
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    3. hemoglobin oxygen therapeutics llc
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENTS
    4. llc “visusmed”
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENT
    5. European Medicines Agency
      1. COMPANY SNAPSHOT
      2. Revenue Analysis
      3. company share analysis
      4. PRODUCT PORTFOLIo
      5. RECENT DEVELOPMENT
    6. aurum biosciences
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENTS
    7. boston therapeutics, inc.
      1. COMPANY SNAPSHOT
      2. Revenue Analysis
      3. PRODUCT PORTFOLIo
      4. RECENT DEVELOPMENT
    8. nanoblood llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    9. nuvox pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENTS
    10. opk biotech llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    11. oxyvita inc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
    12. prolong pharmaceuticals, llc
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIo
      3. RECENT DEVELOPMENT
  17. questionnaire
  18. related reports

표 목록

TABLE 1 global Artificial blood substitutes Market, Product Type, 2019-2028 (USD Thousand)

TABLE 2 global Hemoglobin-Based Oxygen Carries (HBOCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 3 global HEMOGLOBIN-based oxygen carriers (HBOCs) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)

TABLE 4 global Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 5 global Perfluorocarbon (PFCS) in Artificial blood substitutes Market, by Product Type, 2019-2028 (USD Thousand)

TABLE 6 global Artificial blood substitutes Market, by Source, 2019-2028 (USD Thousand)

TABLE 7 global animal blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 8 global human blood in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 9 global microorganism based recombinant hb in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 10 global stem cells in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 11 global synthetic polymers in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 12 global Artificial blood substitutes Market, by Application, 2019-2028 (USD Thousand)

TABLE 13 global injuries in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 14 global cardiovascular diseases in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 15 global organ transplant in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 16 global maternal condition in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 17 global malignant neoplasma in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 18 global neonatal conditions in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 19 global Artificial blood substitutes Market, by End user, 2019-2028 (USD Thousand)

TABLE 20 global hospitals and clinics in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 21 global blood banks in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 22 global others in Artificial blood substitutes Market, by region, 2019-2028 (USD Thousand)

TABLE 23 GLOBAL Artificial blood substitutes MARKET, BY REGION, 2021-2028 (USD THOUSAND)

TABLE 24 North AMERICA Artificial blood substitutes Market, By country, 2019-2028 (USD Thousand)

TABLE 25 NORTH AMERICA Artificial blood substitutes Market, By Product type, 2019-2028 (USD Thousand)

TABLE 26 North America Hemoglobin-Based Oxygen Carries (HBOCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 27 North America Perfluorocarbon (PFCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 28 North America Artificial Blood Substitutes Market, By Source, 2019-2028 (USD Thousand)

TABLE 29 North America Artificial Blood Substitutes Market, By Application, 2019-2028 (USD Thousand)

TABLE 30 North America Artificial Blood Substitutes Market, By End User, 2019-2028 (USD Thousand)

TABLE 31 U.S. Artificial blood substitutes Market, By Product type, 2019-2028 (USD Thousand)

TABLE 32 U.S. Hemoglobin-Based Oxygen Carries (HBOCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 33 U.S. Perfluorocarbon (PFCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 34 U.S. Artificial Blood Substitutes Market, By Source, 2019-2028 (USD Thousand)

TABLE 35 U.S. Artificial Blood Substitutes Market, By Application, 2019-2028 (USD Thousand)

TABLE 36 U.S. Artificial Blood Substitutes Market, By End User, 2019-2028 (USD Thousand)

TABLE 37 MEXICO Artificial blood substitutes Market, By Product type, 2019-2028 (USD Thousand)

TABLE 38 MEXICO Hemoglobin-Based Oxygen Carries (HBOCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 39 MEXICO Perfluorocarbon (PFCS) In Artificial Blood Substitutes Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 40 MEXICO Artificial Blood Substitutes Market, By Source, 2019-2028 (USD Thousand)

TABLE 41 MEXICO Artificial Blood Substitutes Market, By Application, 2019-2028 (USD Thousand)

TABLE 42 MEXICO Artificial Blood Substitutes Market, By End User, 2019-2028 (USD Thousand)

TABLE 43 Middle East & Africa artificial blood substitutes market, By COUNTRY, 2019-2028 (USD Thousand)

TABLE 44 Middle East & Africa artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 45 Middle East & Africa Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 46 Middle East & Africa perfluorocarbon (pfcs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 47 Middle East & Africa artificial blood substitutes market, By Source, 2019-2028 (USD thousand)

TABLE 48 Middle East & Africa artificial blood substitutes market, By application, 2019-2028 (USD thousand)

TABLE 49 Middle East & Africa artificial blood substitutes market, By end user, 2019-2028 (USD thousand)

TABLE 50 South Africa artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 51 South Africa Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 52 South Africa perfluorocarbon (pfcs) in artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 53 South Africa artificial blood substitutes market, By Source, 2019-2028 (USD thousand)

TABLE 54 South Africa artificial blood substitutes market, By application, 2019-2028 (USD thousand)

TABLE 55 South Africa artificial blood substitutes market, By end user, 2019-2028 (USD thousand)

TABLE 56 rest of Middle East & Africa artificial blood substitutes market, By product type, 2019-2028 (USD thousand)

TABLE 57 Europe artificial blood substitute Market, By COUNTRY, 2019-2028 (USD Thousand)

TABLE 58 EUROPE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 59 Europe Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 60 Europe Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 61 Europe artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 62 Europe artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 63 Europe artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 64 FRANCE artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 65 FRANCE Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 66 FRANCE Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 67 FRANCE artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 68 FRANCE artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 69 FRANCE artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 70 RUSSIA artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 71 RUSSIA Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 72 RUSSIA Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 73 RUSSIA artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 74 RUSSIA artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 75 RUSSIA artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 76 NETHERLAND artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 77 NETHERLAND Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 78 NETHERLAND Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 79 NETHERLAND artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 80 NETHERLAND artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 81 NETHERLAND artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 82 U.K. artificial blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 83 U.K. Hemoglobin-Based Oxygen Carries (HBOCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 84 U.K. Perfluorocarbon (PFCS) In artificial Blood Substitute Market, By Product Type, 2019-2028 (USD Thousand)

TABLE 85 U.K. artificial Blood Substitute Market, By Source, 2019-2028 (USD Thousand)

TABLE 86 U.K. artificial Blood Substitute Market, By Application, 2019-2028 (USD Thousand)

TABLE 87 U.K. artificial Blood Substitute Market, By End User, 2019-2028 (USD Thousand)

TABLE 88 REST OF EUROPE ARTIFICIAL blood substitute Market, By Product type, 2019-2028 (USD Thousand)

TABLE 89 Asia-Pacific artificial blood substitute market, By COUNTRY, 2019-2028 (USD Thousand)

TABLE 90 asia-pacific artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 91 asia-pacific Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 92 asia-pacific perfluorocarbon (pfcs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 93 asia-pacific artificial blood substitute market, By Source, 2019-2028 (USD thousand)

TABLE 94 asia-pacific artificial blood substitute market, By application, 2019-2028 (USD thousand)

TABLE 95 asia-pacific artificial blood substitute market, By end user, 2019-2028 (USD thousand)

TABLE 96 China artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 97 China Hemoglobin-based oxygen carriers (HBOCs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 98 China perfluorocarbon (pfcs) in artificial blood substitute market, By product type, 2019-2028 (USD thousand)

TABLE 99 China artificial blood substitute market, By Source, 2019-2028 (USD thousand)

TABLE 100 China artificial blood substitute market, By application, 2019-2028 (USD thousand)

TABLE 101 China artificial blood substitute market, By end user, 2019-2028 (USD thousand)

TABLE 102 rest of asia-pacific artificial blood substitute market, By product type, 2019-2028 (USD thousand)

그림 목록

FIGURE 1 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: segmentation

FIGURE 2 global artificial blood substitutes market: data triangulation

FIGURE 3 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: DROC ANALYSIS

FIGURE 4 Global artificial blood substitutes market: GLOBAL vs REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: market APPLICATION COVERAGE GRID

FIGURE 9 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: DBMR VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET: SEGMENTATION

FIGURE 11 north america is expected to DOMINATE THE global artificial blood substitutes market AND GROWing WITH THE HIGHEST share IN the forecast period of 2021 To 2028

FIGURE 12 increased DEMAND FOR BLOOD TRANSFUSION is expected to drive the global artificial blood substitutes market in THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 haemoglobin-based oxygen carriers (hbocs) SEgment is expected to account for the largest share of the GLOBAL ARTIFICIAL BLOOD SUBSTITUTES MARKET in 2021 & 2028

FIGURE 14 north america is the fastest growing market for artificial blood substitutes manufacturers in the forEcast period of 2021 to 2028

FIGURE 15 PATENT REGISTERED FOR ARTIFICIAL BLOOD SUBSTITUTES, BY COUNTRY

FIGURE 16 PATENT REGISTERED YEAR (2017 - 2021)

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF GLOBAL artificial blood substituteS MARKET

FIGURE 18 global Artificial blood substitutes Market, By Product Type, 2020

FIGURE 19 global Artificial blood substitutes Market, By Source, 2020

FIGURE 20 global Artificial blood substitutes Market, By Application, 2020

FIGURE 21 global Artificial blood substitutes Market, By End user, 2020

FIGURE 22 GLOBAL Artificial blood substitutes market: SNAPSHOT (2020)

FIGURE 23 GLOBAL Artificial blood substitutes market: BY REGION (2020)

FIGURE 24 GLOBAL Artificial blood substitutes market: BY REGION (2021 & 2028)

FIGURE 25 GLOBAL Artificial blood substitutes market: BY REGION (2020 & 2028)

FIGURE 26 GLOBAL Artificial blood substitutes market: BY Product Type (2021-2028)

FIGURE 27 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: SNAPSHOT (2020)

FIGURE 28 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2020)

FIGURE 29 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 30 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 31 North America ARTIFICIAL BLOOD SUBSTITUTES MARKET: BY product type (2021-2028)

FIGURE 32 Middle East & Africa artificial blood substitutes market: SNAPSHOT (2020)

FIGURE 33 Middle East & Africa artificial blood substitutes market: BY COUNTRY (2020)

FIGURE 34 Middle East & Africa artificial blood substitutes market: BY COUNTRY (2021 & 2028)

FIGURE 35 Middle East & Africa artificial blood substitutes market: BY COUNTRY (2020 & 2028)

FIGURE 36 Middle East & Africa artificial blood substitutes market: BY PRODUCT TYPE (2021 & 2028)

FIGURE 37 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: SNAPSHOT (2020)

FIGURE 38 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020)

FIGURE 39 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2021 & 2028)

FIGURE 40 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY COUNTRY (2020 & 2028)

FIGURE 41 Europe ARTIFICIAL BLOOD SUBSTITUTE MARKET: BY product type (2021-2028)

FIGURE 42 Asia-Pacific artificial blood substitute market: SNAPSHOT (2020)

FIGURE 43 Asia-Pacific artificial blood substitute market: BY COUNTRY (2020)

FIGURE 44 Asia-Pacific artificial blood substitute market: BY COUNTRY (2021 & 2028)

FIGURE 45 Asia-Pacific artificial blood substitute market: BY COUNTRY (2020 & 2028)

FIGURE 46 Asia-Pacific artificial blood substitute market: BY product TYPE (2020 & 2028)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The market is segmented based on , By Product Type (Perflurocarbon (PFCs), Hemoglobin-Based Oxygen Carries (HBOCs)), Source (Human Blood, Animal Blood, Microorganism Based Recombinant HB, Synthetic Polymers, Stem Cells), Application (Cardiovascular Diseases, Malignant Neoplasma, Injuries, Neonatal Conditions, Organ Transplant, Maternal Condition), End User (Hospital and Clinics, Blood Banks, Others) – Industry Trends and Forecast to 2030. .
The Global Artificial Blood Substitutes Market size was valued at USD 6.67 USD Million in 2022.
The Global Artificial Blood Substitutes Market is projected to grow at a CAGR of 20.4% during the forecast period of 2023 to 2030.
The major players operating in the market include Aurum Biosciences, HEMARINA, Hemoglobin Oxygen Therapeutics LLC, KaloCyte , SpheriTech , Centrum Medyczne VisusMed, European Medicines Agency, OPK Biotech , NuvOx Pharma, Prolong Pharmaceuticals LLC, Boston Pharmaceuticals, OXYVITA , NanoBlood LLC.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.

관련 페이지 탐색

Banner